Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cleveland BioLabs Inc.
DescriptionDual TLR2 and TLR6 agonist derived from a synthetic analog of a naturally occurring Mycoplasma arginini-derived lipopeptide ligand for TLR2 and TLR6
Molecular Target Toll-like receptor 2 (TLR2) ; Toll-like receptor 6 (TLR6)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsTreat acute radiation syndrome (ARS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today